Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 28 peer-reviewed journal articles Updated
Dermatology

What Triggers Pyoderma Gangrenosum Flares? Explained

At a Glance

The best-established trigger for a pyoderma gangrenosum flare is skin trauma, called pathergy, but not every injury causes a flare. Medication changes and associated inflammatory conditions may also matter, while stress and everyday infections are not proven direct triggers.

In this answer

5 sections

01

Skin Trauma and Pathergy

02

Underlying Conditions and Severe Infections

03

Medication Changes

04

The Role of Psychological Stress

05

Creating a Flare Plan

For many people with pyoderma gangrenosum (PG), a flare can seem to happen out of nowhere. However, one of the most recognized triggers is physical trauma to the skin—a phenomenon known as pathergy [1]. While some physical injuries and surgeries are documented triggers for a subset of patients, the role of psychological stress, everyday illnesses, or medication changes is less straightforward [2][3]. It is important to understand what is known about these triggers so you can take practical steps to protect your skin, communicate with your care team, and avoid blaming yourself for an unpredictable disease.

Skin Trauma and Pathergy

A well-documented trigger for PG is physical injury to the skin [1][4]. In up to one-third of people with PG, a new lesion can develop directly at the site of a trauma [5]. This reaction is called pathergy, which means the immune system severely overreacts to an injury, triggering inflammation rather than normal healing.

Pathergy does not happen to every patient, and trauma does not explain every flare. However, reported triggers range from major procedures to everyday occurrences, including:

  • Well-documented: Surgical incisions, reconstructive procedures, and skin biopsies [6][7].
  • Reported: Needle punctures (blood draws, IV lines, or injections) [8][9].
  • Possible aggravators: Minor scratches, bug bites, tight clothing, or minor bumps, which may worsen an existing lesion or occasionally initiate one [5].

Because of pathergy, treating a PG ulcer like a normal surgical wound can be harmful. Routine sharp debridement (cutting away dead tissue) is generally discouraged during an active flare, as the trauma can cause the lesion to spread [10][11]. Wound care should focus on gentle, non-adherent dressings and protecting the area from friction [12]. However, do not refuse debridement or biopsy if your doctor suspects a severe infection or needs to confirm your diagnosis. Biopsies are sometimes necessary to rule out infections, vasculitis, or cancer [13]. Clinicians weigh the risk of pathergy against the need for crucial diagnostic tests, and they will direct your wound care safely [10]. Never attempt harsh cleansing or debridement at home.

Important: You should not avoid medically necessary blood draws, injections, vaccinations, or surgeries. Instead, inform your healthcare providers about your PG so they can choose the safest technique and timing [14].

If you need elective surgery, coordinate a plan with your dermatologist and surgeon. There is no universal preventative regimen, but an individualized plan may involve adjusting your immunomodulatory treatments (medicines that calm the immune system) or taking systemic corticosteroids [15][16]. Never start, stop, or change your medications on your own.

Underlying Conditions and Severe Infections

More than half of people with PG have an associated systemic inflammatory condition, most commonly inflammatory bowel disease (IBD), inflammatory arthritis, or hematologic (blood or bone-marrow) conditions [1]. Sometimes, a PG flare occurs alongside a flare-up of one of these underlying conditions [17]. Not everyone with PG has an associated disease, but your clinician may evaluate you for them.

Everyday infections like a cold are not established by research as direct triggers for a PG flare [3]. However, a PG flare can easily be mistaken for a severe skin infection, as both cause painful, red, worsening wounds [18][19]. Furthermore, open PG wounds are vulnerable to secondary bacterial infections [13][20].

When to Seek Urgent Care: A suspected PG flare should never be used to dismiss a serious infection. Seek same-day medical assessment or emergency care if you experience:

  • A rapidly expanding, painful wound with spreading redness or foul-smelling drainage
  • High fever, chills, or sweating [21]
  • Confusion, fainting, or severe weakness
  • Shortness of breath or rapid deterioration [22]

Medication Changes

Changing or tapering your medications can sometimes precede a flare. Because PG recurrence is relatively common over the years, some patients may require individualized long-term maintenance therapy [23]. For example, lowering the dose of a systemic corticosteroid too quickly may allow ulcers to return [24].

There are also rare, agent-specific case reports of certain medications triggering the onset of PG, such as specific targeted cancer therapies or individual psoriasis biologics [25][26]. These are rare associations, not a class-wide risk. If you suspect a medication is affecting your skin, contact your care team immediately—do not abruptly stop your treatments.

The Role of Psychological Stress

Many patients notice their PG flares during times of intense psychological stress. Living with a chronic, painful disease is inherently stressful. While PG involves complex immune pathways that drive inflammation, systemic inflammation is generally more relevant in severe disease or associated conditions rather than being directly triggered by stress alone [2][27].

Current medical evidence does not establish stress as a direct, predictable cause of individual PG flares [2]. While managing stress is vital for your overall well-being and coping ability, you should never blame yourself for a flare. Getting a new ulcer is a sign of an overactive immune system, not a failure to manage your lifestyle.

Creating a Flare Plan

Because flares can happen unexpectedly, being prepared is your best defense. Work with your dermatologist to create a written flare plan:

  • Prompt evaluation: Know exactly who to call if you notice a new bump, blister, or expanding ulcer [18][28]. Have an after-hours plan.
  • Trauma protection: Use gentle wound care techniques directed by your doctor [10]. Track new lesions with dates and photos.
  • Procedure protocols: Consider carrying a brief medical alert card or letter stating you have PG and a risk of pathergy, so dentists, surgeons, and nurses can contact your dermatologist before procedures [6][14].

Common questions in this guide

What is the most common trigger of a pyoderma gangrenosum flare?
Skin trauma is the best-established trigger. In a reaction called pathergy, the immune system overreacts to an injury and a new ulcer can form at the injured site. This does not happen to everyone with PG, and trauma does not explain every flare.
Can a surgery, biopsy, injection, or blood draw cause a PG lesion?
These procedures can trigger pathergy in some people, but medically necessary procedures should not be avoided. Tell every clinician that you have PG and ask your dermatologist and the procedural team to coordinate the safest approach. Do not refuse a biopsy or treatment needed to diagnose infection or another serious condition.
Does stress or a cold directly cause pyoderma gangrenosum flares?
Current evidence does not establish psychological stress or everyday infections as predictable direct causes of individual PG flares. Stress management can still support well-being and coping, and open PG wounds can develop secondary bacterial infections. A worsening wound should be assessed rather than assumed to be stress or a routine infection.
Can changing my PG medication lead to a flare?
A flare can follow medication changes, particularly if a systemic corticosteroid is reduced too quickly. Rare case reports also describe PG beginning after certain medicines, but these associations are uncommon and specific to individual drugs. Contact your care team before stopping, starting, or changing any treatment.
What should I do if I think a PG flare is infected?
Seek same-day medical assessment for a rapidly expanding painful wound, spreading redness, foul-smelling drainage, fever, chills, confusion, fainting, severe weakness, shortness of breath, or rapid deterioration. PG wounds can develop secondary bacterial infections, and a severe infection can resemble a flare. Do not use the possibility of PG to dismiss urgent symptoms.
How can I prepare for a procedure if I have pyoderma gangrenosum?
Tell the surgeon, dentist, nurse, or other clinician about your PG and history of pathergy before a procedure. Your dermatologist and procedural team can decide whether timing or immunomodulatory treatment needs individual planning; there is no single preventive regimen for everyone. A medical alert card or letter can help communicate this risk.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific signs should prompt me to contact you immediately, and what is the after-hours plan if the office is closed?
  2. 2.If I need a medically necessary blood draw, IV, or vaccine, what instructions can I give the healthcare worker to minimize tissue trauma?
  3. 3.How should we coordinate my care and adjust my medications if I need an elective surgery or dental procedure?
  4. 4.What is the safest way to clean and bandage my wounds at home without causing unnecessary trauma?
  5. 5.Based on my history, should I be on an individualized maintenance medication to help prevent future flares?
  6. 6.Should we create a short medical alert card or letter explaining my PG and pathergy risk for other clinicians?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Biopsy or Culture Trigger Pathergy in PG? ExplainedCan a PG Wound Culture Be Positive Without Infection?Can Inflammatory Arthritis Start Before Pyoderma Gangrenosum?Can PG Subtypes Change Both Treatment and Prognosis?How Common Is Pyoderma Gangrenosum and Who Gets It?How Is Pyoderma Gangrenosum Distinguished From Infection?How Long Does a Pyoderma Gangrenosum Ulcer Take to Heal?How Is a Skin Biopsy Done for Pyoderma Gangrenosum?Can Pyoderma Gangrenosum Be Linked to Leukemia or MDS?Prednisone vs Cyclosporine for PG: How Is Treatment Chosen?What Are Delphi Criteria and PARACELSUS Scores for PG?What Are Prednisone Side Effects in PG and How Is It Tapered?What Causes Pyoderma Gangrenosum, and Is It Hereditary?What Diseases Can Mimic Pyoderma Gangrenosum? ExplainedWhat Should I Be Screened for After Pyoderma Gangrenosum?What Bowel Symptoms Suggest IBD with Pyoderma Gangrenosum?How Is Cyclosporine Monitored in Pyoderma Gangrenosum?What Tests Diagnose Pyoderma Gangrenosum and Other Causes?When Is a Pyoderma Gangrenosum Ulcer an Emergency?

References

References (28)
  1. 1

    Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

    Kridin K, Cohen AD, Amber KT

    American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.

    PMID: 29721816
  2. 2

    Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

    Maronese CA, Pimentel MA, Li MM, et al.

    American journal of clinical dermatology 2022; (23(5)):615-634 doi:10.1007/s40257-022-00699-8.

    PMID: 35606650
  3. 3

    Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C.

    Pourmorteza M, Tawadros F, Bader G, et al.

    The American journal of case reports 2016; (17()):434-8 doi:10.12659/ajcr.898611.

    PMID: 27345376
  4. 4

    The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

    Ashchyan HJ, Butler DC, Nelson CA, et al.

    JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.

    PMID: 29450453
  5. 5

    Recalcitrant Pyoderma Gangrenosum of the Face: A Case Report.

    Jiang M, Zhang G, Hsieh TY

    Cureus 2024; (16(3)):e57136 doi:10.7759/cureus.57136.

    PMID: 38681354
  6. 6

    A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy.

    Zuo KJ, Fung E, Tredget EE, Lin AN

    Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2015; (68(3)):295-303.

    PMID: 25589459
  7. 7

    Pyoderma Gangrenosum: A Nightmare for Breast Surgery-Two Case Reports.

    Akoğlu G, Demiriz M, Yılmaz KB

    European journal of breast health 2025; (21(1)):80-84 doi:10.4274/ejbh.galenos.2024.2024-7-5.

    PMID: 39744929
  8. 8

    Multiple Pyoderma Gangrenosum Overlying AV Fistula Treated With Colchicine: A Case Report.

    Derstenfeld A, Meunier RS, Bouchard J, Mereniuk A

    Canadian journal of kidney health and disease 2024; (11()):20543581241284749 doi:10.1177/20543581241284749.

    PMID: 39371934
  9. 9

    Postsurgical pyoderma gangrenosum after an autologous stem cell transplantation for multiple myeloma.

    Bittencourt MCB, Atanazio MJ, Xavier EM, Costa SF

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-222286.

    PMID: 29305364
  10. 10

    Rare Presentation of Postsurgical Pyoderma Gangrenosum Presenting as Necrotizing Soft Tissue Infection.

    Flynn RL, Chowdhury MH, Rudolph J, Einstein S

    Advances in skin & wound care 2019; (32(11)):507-511 doi:10.1097/01.ASW.0000579692.74662.bb.

    PMID: 31498172
  11. 11

    The role of negative pressure wound therapy (NPWT) on the treatment of pyoderma gangrenosum: A systematic review and personal experience.

    Almeida IR, Coltro PS, Gonçalves HOC, et al.

    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2021; (29(3)):486-494 doi:10.1111/wrr.12910.

    PMID: 33772964
  12. 12

    Local wound care management for pyoderma gangrenosum.

    Haroon A, Gillespie J, Roland-McGowan J, et al.

    International wound journal 2024; (21(11)):e70135 doi:10.1111/iwj.70135.

    PMID: 39557450
  13. 13

    Pyoderma Gangrenosum After Bilateral Total Knee Arthroplasty.

    Loomis R, Merrit M, Aleshin MA, et al.

    Arthroplasty today 2021; (11()):73-79 doi:10.1016/j.artd.2021.07.003.

    PMID: 34485653
  14. 14

    Successful revision surgery after postsurgical pyoderma gangrenosum following reduction mammaplasty: A case report.

    Tao LA, Cafro C, Rosser M, et al.

    JPRAS open 2026; (51()):357-362 doi:10.1016/j.jpra.2026.06.012.

    PMID: 42542602
  15. 15

    Hemiarthroplasty in a patient with femoral neck fracture and pyoderma gangrenosum: a case report and review of the literature.

    Antoni A, Trautinger F, Heinz T, Hajdu S

    Journal of medical case reports 2020; (14(1)):8 doi:10.1186/s13256-019-2329-8.

    PMID: 31931877
  16. 16

    Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.

    Ebrad S, Severyns M, Benzakour A, et al.

    International orthopaedics 2018; (42(2)):239-245 doi:10.1007/s00264-017-3672-2.

    PMID: 29119297
  17. 17

    Atypical Visceral Involvement of Pyoderma Gangrenosum.

    Ruiz NM, Ibarz JO, López SR, et al.

    Ochsner journal 2026; (26(3)):247-250 doi:10.31486/toj.25.0094.

    PMID: 42746439
  18. 18

    Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

    Maverakis E, Ma C, Shinkai K, et al.

    JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.

    PMID: 29450466
  19. 19

    Case Study on Management of Postsurgical Pyoderma Gangrenosum After Spinal Surgery.

    Ratliff CR

    Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society 2019; (46(6)):543-546 doi:10.1097/WON.0000000000000587.

    PMID: 31651797
  20. 20

    Probable pyoderma gangrenosum complicated with cutaneous Aspergillus flavus infection: case report.

    Sun S, Zhu M, Wen C

    Frontiers in medicine 2026; (13()):1806433 doi:10.3389/fmed.2026.1806433.

    PMID: 42100284
  21. 21

    Pyoderma Gangrenosum After Insertion of a Hemodialysis Catheter: Koebner Phenomenon, Systemic Inflammatory Response Syndrome, and a Delay in Diagnosis.

    Alosaimi MM, Sebzali F, Iqbal A, et al.

    Canadian journal of kidney health and disease 2022; (9()):20543581221120618 doi:10.1177/20543581221120618.

    PMID: 36160315
  22. 22

    Clinical Features of Neutrophilic Dermatosis Variants Resembling Necrotizing Fasciitis.

    Sanchez IM, Lowenstein S, Johnson KA, et al.

    JAMA dermatology 2019; (155(1)):79-84 doi:10.1001/jamadermatol.2018.3890.

    PMID: 30383110
  23. 23

    Recurrence after healing in pyoderma gangrenosum: a prospective registry-based cohort study.

    Gillespie J, Roland-McGowan J, Downey K, et al.

    EClinicalMedicine 2026; (98()):104086 doi:10.1016/j.eclinm.2026.104086.

    PMID: 42495104
  24. 24

    Pyoderma gangrenosum as a manifestation of multisystem autoimmunity in a patient with giant cell arteritis, optic neuritis and rheumatoid arthritis.

    Aftab G, Tabassum S, Fatima S, Ali S

    BMJ case reports 2026; (19(6)) doi:10.1136/bcr-2025-271851.

    PMID: 42230006
  25. 25

    Pembrolizumab-associated pyoderma gangrenosum in a patient with metastatic squamous cell carcinoma.

    Tsibris H, Lian C, Ho A

    Dermatology online journal 2021; (27(4)).

    PMID: 33999581
  26. 26

    Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy.

    Xin W, Gu L, Du F, et al.

    Frontiers in immunology 2025; (16()):1581996 doi:10.3389/fimmu.2025.1581996.

    PMID: 40260260
  27. 27

    Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.

    Flora A, Kozera E, Frew JW

    Experimental dermatology 2022; (31(4)):498-515 doi:10.1111/exd.14534.

    PMID: 35114021
  28. 28

    Treatment of Pyoderma Gangrenosum.

    Tan MG, Tolkachjov SN

    Dermatologic clinics 2024; (42(2)):183-192 doi:10.1016/j.det.2023.12.002.

    PMID: 38423680

This page is for informational purposes only and does not constitute medical advice about pyoderma gangrenosum. Contact your dermatologist or care team before changing treatment or if a wound rapidly worsens.

Get notified when new evidence is published on Pyoderma gangrenosum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.